Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313238215> ?p ?o ?g. }
- W4313238215 endingPage "111" @default.
- W4313238215 startingPage "111" @default.
- W4313238215 abstract "Nanoprobes provide advantages for real-time monitoring of tumor markers and tumorigenesis during cancer progression and development. Epidermal growth factor receptor (EGFR) is a key protein that plays crucial roles for tumorigenesis and cancer therapy of lung cancers. Here, we show a carbon-based nanoprobe, nanodiamond (ND), which can be applied for targeting EGFR and monitoring tumorigenesis of human lung cancer cells in vitro and in vivo. The optimal fluorescent intensities of ND particles were observed in the human lung cancer cells and nude mice under in vivo imaging system. The fluorescence signal of ND particles can be real-time detected in the xenografted human lung tumor formation of nude mice. Moreover, the ND-conjugated specific EGFR antibody cetuximab (Cet) can track the location and distribution of EGFR proteins of lung cancer cells in vitro and in vivo. ND-Cet treatment increased cellular uptake ability of nanocomposites in the EGFR-expressed cells but not in the EGFR-negative lung cancer cells. Interestingly, single ND-Cet complex can be directly observed on the protein G bead by immunoprecipitation and confocal microscopy. Besides, the EGFR proteins were transported to lysosomes for degradation. Together, this study demonstrates that ND-conjugated Cet can apply for targeting EGFR and monitoring tumorigenesis during lung cancer progression and therapy." @default.
- W4313238215 created "2023-01-06" @default.
- W4313238215 creator A5003101270 @default.
- W4313238215 creator A5008680951 @default.
- W4313238215 creator A5015426670 @default.
- W4313238215 creator A5023688740 @default.
- W4313238215 creator A5028117890 @default.
- W4313238215 creator A5030223287 @default.
- W4313238215 creator A5034065291 @default.
- W4313238215 creator A5034403218 @default.
- W4313238215 creator A5053660192 @default.
- W4313238215 creator A5059995303 @default.
- W4313238215 creator A5076572432 @default.
- W4313238215 creator A5083720692 @default.
- W4313238215 date "2022-12-28" @default.
- W4313238215 modified "2023-10-16" @default.
- W4313238215 title "Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody" @default.
- W4313238215 cites W1967466247 @default.
- W4313238215 cites W1986728375 @default.
- W4313238215 cites W1996275566 @default.
- W4313238215 cites W1997488475 @default.
- W4313238215 cites W2004439203 @default.
- W4313238215 cites W2011529228 @default.
- W4313238215 cites W2012629036 @default.
- W4313238215 cites W2017873711 @default.
- W4313238215 cites W2019579459 @default.
- W4313238215 cites W2028009636 @default.
- W4313238215 cites W2043696829 @default.
- W4313238215 cites W2046775626 @default.
- W4313238215 cites W2049919175 @default.
- W4313238215 cites W2058620780 @default.
- W4313238215 cites W2068115483 @default.
- W4313238215 cites W2068125497 @default.
- W4313238215 cites W2068416436 @default.
- W4313238215 cites W2073759231 @default.
- W4313238215 cites W2076395634 @default.
- W4313238215 cites W2086439684 @default.
- W4313238215 cites W2086724229 @default.
- W4313238215 cites W2089984379 @default.
- W4313238215 cites W2093036951 @default.
- W4313238215 cites W2100794900 @default.
- W4313238215 cites W2101778620 @default.
- W4313238215 cites W2145240677 @default.
- W4313238215 cites W2146595615 @default.
- W4313238215 cites W2147219712 @default.
- W4313238215 cites W2159098445 @default.
- W4313238215 cites W2161821474 @default.
- W4313238215 cites W2163950832 @default.
- W4313238215 cites W2285593825 @default.
- W4313238215 cites W2549111609 @default.
- W4313238215 cites W2749208559 @default.
- W4313238215 cites W2898470884 @default.
- W4313238215 cites W2908266099 @default.
- W4313238215 cites W2909774934 @default.
- W4313238215 cites W2909886713 @default.
- W4313238215 cites W2910175501 @default.
- W4313238215 cites W2911291235 @default.
- W4313238215 cites W2913052801 @default.
- W4313238215 cites W2913136169 @default.
- W4313238215 cites W2982461386 @default.
- W4313238215 cites W3012545048 @default.
- W4313238215 cites W3018616624 @default.
- W4313238215 cites W3036528748 @default.
- W4313238215 cites W3103758115 @default.
- W4313238215 cites W3118238600 @default.
- W4313238215 cites W3118474372 @default.
- W4313238215 cites W3134254717 @default.
- W4313238215 cites W3135875197 @default.
- W4313238215 cites W3137629900 @default.
- W4313238215 cites W3196887107 @default.
- W4313238215 cites W4200162061 @default.
- W4313238215 cites W4210506021 @default.
- W4313238215 cites W4210588855 @default.
- W4313238215 cites W4210804078 @default.
- W4313238215 cites W4212963329 @default.
- W4313238215 cites W4221082366 @default.
- W4313238215 cites W4221110880 @default.
- W4313238215 cites W4225137479 @default.
- W4313238215 cites W4289992982 @default.
- W4313238215 cites W4296935329 @default.
- W4313238215 cites W4307939086 @default.
- W4313238215 cites W4362094783 @default.
- W4313238215 doi "https://doi.org/10.3390/pharmaceutics15010111" @default.
- W4313238215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36678740" @default.
- W4313238215 hasPublicationYear "2022" @default.
- W4313238215 type Work @default.
- W4313238215 citedByCount "1" @default.
- W4313238215 countsByYear W43132382152023 @default.
- W4313238215 crossrefType "journal-article" @default.
- W4313238215 hasAuthorship W4313238215A5003101270 @default.
- W4313238215 hasAuthorship W4313238215A5008680951 @default.
- W4313238215 hasAuthorship W4313238215A5015426670 @default.
- W4313238215 hasAuthorship W4313238215A5023688740 @default.
- W4313238215 hasAuthorship W4313238215A5028117890 @default.
- W4313238215 hasAuthorship W4313238215A5030223287 @default.
- W4313238215 hasAuthorship W4313238215A5034065291 @default.
- W4313238215 hasAuthorship W4313238215A5034403218 @default.
- W4313238215 hasAuthorship W4313238215A5053660192 @default.